About GRI Bio, Inc. GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio’s therapies are ...

A new Marvel movie, The Fantastic Four: First Steps, is set to arrive in July, and fans are already invested in its marketing ...

Artios Pharma Limited (“Artios”), a clinical-stage biotech company led by pioneers of DNA damage response (“DDR”) drug development, today announced that the company’s abstract featuring clinical trial ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad ...

The Ottawa International Animation Festival (OIAF) reveals its 2025 poster designed by Academy Award-winning Canadian ...

Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

Emetogenic chemotherapy regimens and back pain were associated with higher symptom burden in older, vs younger, patients with ...

Amir Karami, Ph.D., associate professor of Quantitative Methods and Business Analytics in the Collat School of Business, will ...

A lower apixaban dose is indicated in patients with an eGFR less than 30 mL/min/1.73 m2, regardless of dialysis status.

Connections: Sports Edition is a fantastic way to engage your brain while exploring the fascinating world of sports. Whether you’re solving today’s puzzle or preparing for tomorrow’s challenge, ...

PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...